Sitemap Klarity story Join us Medication Service About us

HSA & FSA accepted; best-value for top quality care

Same-day mental health, weight loss, and primary care appointments available

Excellent

based on 0 reviews

Accept major insurances and cash-pay

HSA & FSA accepted; best-value for top quality care

Same-day mental health, weight loss, and primary care appointments available

Excellent

based on 0 reviews

Accept major insurances and cash-pay

Back

Published: Feb 28, 2026

Is telehealth allowed to prescribe Ozempic in California?

Written by Klarity Editorial Team

Published: Feb 28, 2026

Is telehealth allowed to prescribe Ozempic in California?

Table of contents

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve probably wondered: Can I actually get these prescribed through telehealth? The short answer is yes—but the specifics depend on where you live and how you approach treatment.

With obesity affecting over 40% of American adults and GLP-1 medications proving remarkably effective, telehealth has become a game-changer for accessing weight loss care. However, navigating the patchwork of federal and state regulations can feel overwhelming. This guide breaks down everything you need to know about legally and safely obtaining weight loss medications online in 2025.

Understanding the Legal Framework for Telehealth Weight Loss Prescriptions

Federal Law: The Good News for GLP-1 Medications

Here’s the critical point many people miss: GLP-1 medications like Wegovy, Ozempic, and Mounjaro are not controlled substances. This means they’re exempt from the Ryan Haight Act’s in-person examination requirement that applies to drugs like Adderall or opioids.

Under federal law, there is no blanket requirement for an in-person visit before prescribing these weight loss medications via telehealth. A licensed healthcare provider can evaluate you through a video consultation and send a prescription electronically to your pharmacy—completely legally.

The confusion often stems from COVID-era headlines about controlled substance prescribing. While the DEA has extended temporary flexibilities for controlled medications through December 31, 2025, these rules don’t impact GLP-1 weight loss drugs, which have always been permissible via telehealth under federal law.

State Regulations: Where Things Get Nuanced

While federal law provides the green light, individual states can impose additional requirements. Some states have adopted a more cautious approach to telehealth prescribing, particularly for obesity medications that were historically subject to abuse (think older appetite suppressants like phentermine).

The requirements fall into several categories:

States with No Special Restrictions (e.g., California, New York, Washington, Illinois, Pennsylvania)
These states fully embrace telehealth for weight loss medications. A comprehensive video consultation establishing a valid patient-provider relationship is sufficient to prescribe. No in-person visit is legally mandated.

States Requiring Initial In-Person Evaluation (e.g., Arkansas, Delaware, Georgia, New Jersey, Texas, Virginia)
These states either explicitly require or strongly expect an initial physical examination before starting weight loss treatment—though follow-ups can occur via telehealth. The rationale typically centers on establishing baseline health metrics and ruling out contraindications.

States with Enhanced Documentation Requirements (e.g., Florida, Connecticut, Virginia)
These states don’t necessarily require in-person visits but mandate specific protocols: comprehensive lifestyle counseling, documented diet and exercise plans, regular follow-up schedules (Florida requires visits at least every 3 months), and sometimes baseline laboratory work.

It’s worth noting that even in states with stricter rules, telehealth remains an option—you just may need to coordinate an initial local exam or ensure your telehealth provider operates within your state’s specific framework.

Who Can Prescribe Weight Loss Medications via Telehealth?

Physicians and Physician Assistants

Medical Doctors (MDs) and Doctors of Osteopathic Medicine (DOs) can prescribe GLP-1 weight loss medications in all 50 states via telehealth, provided they’re licensed in the state where you’re physically located during the consultation.

Physician Assistants (PAs) can also prescribe these medications in every state, though they typically work under physician supervision or collaboration agreements. The level of autonomy varies by state.

Nurse Practitioners: Expanding Authority

The landscape for Nurse Practitioners has evolved dramatically. As of 2025, over 30 states plus Washington D.C. grant NPs full practice authority, meaning they can prescribe medications independently without physician oversight after meeting experience requirements.

States with full NP independence include:

California (after 3+ years supervised experience)
New York (after 3,600 clinical hours)
Washington, Oregon, Arizona, New Mexico
Connecticut (after 3 years collaboration)
Montana, Idaho, Nevada, and many others

In states with restricted or collaborative practice (like Texas, Florida, Georgia, Pennsylvania), NPs can still prescribe GLP-1 medications but must operate under formal agreements with physicians. This doesn’t mean the care is inferior—it simply reflects different regulatory structures.

What this means for patients: When using a telehealth platform like Klarity Health, you might consult with an NP, PA, or MD. All are qualified to prescribe weight loss medications within their scope of practice. Klarity ensures all providers are properly licensed and credentialed in your state, so you can feel confident about the legitimacy of your care.

State-by-State Breakdown: What to Expect Where You Live

Arkansas

Telehealth Allowed: Yes, with strict standards
In-Person Required: Initial visit must be in-person
Provider Authority: NPs require physician collaboration
Special Notes: Arkansas maintains some of the nation’s most restrictive telehealth regulations, though reforms are under consideration for 2026

California

Telehealth Allowed: Yes, explicitly permitted
In-Person Required: No
Provider Authority: NPs can practice independently (after experience requirements)
Special Notes: Progressive telehealth environment with no unique barriers to weight loss prescribing

Connecticut

Telehealth Allowed: Yes, permanent law in place
In-Person Required: No
Provider Authority: NPs independent after 3 years collaboration
Special Notes: Must include behavioral counseling and documented diet/exercise plan

Delaware

Telehealth Allowed: Yes
In-Person Required: Initial physical exam required
Provider Authority: NPs independent after 2 years collaboration
Special Notes: Initial visit requirement helps ensure comprehensive baseline assessment

Florida

Telehealth Allowed: Yes
In-Person Required: No (though initial exam recommended)
Provider Authority: NPs have limited independence; primarily collaborative
Special Notes: State law requires BMI ≥30 and follow-up visits at least every 3 months during treatment—one of the more structured approaches to obesity medication management

Georgia

Telehealth Allowed: Yes
In-Person Required: Initial in-person exam required
Provider Authority: Collaborative (NPs/PAs recently gained authority to prescribe Schedule II with delegation as of July 2024)
Special Notes: The 2024 law expanded NP/PA prescribing scope significantly

Illinois

Telehealth Allowed: Yes, permanent law
In-Person Required: No
Provider Authority: NPs work under physician agreements
Special Notes: Straightforward telehealth access; mandatory e-prescribing for all medications

Mississippi

Telehealth Allowed: Yes
In-Person Required: Initial in-person evaluation required
Provider Authority: NPs require physician collaboration (full practice authority bills pending)
Special Notes: Conservative approach; watching for legislative changes in 2026

New Jersey

Telehealth Allowed: Yes
In-Person Required: Comprehensive initial in-person exam plus labs required
Provider Authority: NPs work under joint protocols with physicians
Special Notes: Among the most rigorous requirements—initial evaluation must include extensive history, physical exam, laboratory work, and psychological screening

New York

Telehealth Allowed: Yes, explicitly permitted
In-Person Required: No
Provider Authority: NPs independent after 3,600 supervised hours
Special Notes: Progressive telehealth policies; mandatory e-prescribing includes GLP-1 medications

North Dakota

Telehealth Allowed: Yes
In-Person Required: Initial hands-on evaluation expected
Provider Authority: NPs have full practice authority
Special Notes: Despite requiring initial in-person exam, ND otherwise embraces telehealth broadly

Pennsylvania

Telehealth Allowed: Yes (via 2020 law)
In-Person Required: No
Provider Authority: NPs require physician collaboration
Special Notes: Clean telehealth framework, though NP independence legislation remains pending

South Carolina

Telehealth Allowed: Yes
In-Person Required: Initial in-person visit required
Provider Authority: Collaborative practice with written protocols
Special Notes: Initial visit and periodic evaluations mandated; conservative regulatory approach

Texas

Telehealth Allowed: Yes (since 2017)
In-Person Required: Generally expected initially
Provider Authority: NPs/PAs require physician delegation agreements
Special Notes: Strict oversight—prescriptive authority requires documented physician agreements. Standard of care typically involves initial in-person exam. NP independence efforts have repeatedly failed in state legislature.

Utah

Telehealth Allowed: Yes, widely utilized
In-Person Required: Initial in-person exam encouraged
Provider Authority: NPs have full practice authority (as of 2023)
Special Notes: Recent expansion of NP autonomy; baseline evaluation recommended

Virginia

Telehealth Allowed: Yes
In-Person Required: Initial physical exam and labs required
Provider Authority: NPs independent after 2 years experience
Special Notes: Board of Medicine mandates comprehensive initial work-up including physical exam, laboratory tests, personalized diet/exercise plan, and 30-day follow-up visit

Washington

Telehealth Allowed: Yes, pioneering telehealth state
In-Person Required: No
Provider Authority: NPs have full practice authority
Special Notes: No restrictions; progressive policies. Note: Washington’s My Health My Data Act (2023) adds enhanced privacy protections for sensitive health information

Understanding the Medications: What You Can Get via Telehealth

Wegovy (Semaglutide 2.4mg)

Classification: Not a controlled substance
FDA Approval: Chronic weight management for adults with BMI ≥30 or ≥27 with weight-related conditions
Telehealth Status: Fully prescribable via telehealth nationwide
Typical Supply: 30-day initial supply; up to 90 days for stable patients
Important Note: FDA banned routine compounding of semaglutide effective May 2025 due to safety concerns. Only FDA-approved branded versions should be prescribed.

Ozempic (Semaglutide 0.5-1mg)

Classification: Not controlled
FDA Approval: Type 2 diabetes (used off-label for weight loss)
Telehealth Status: Can be prescribed via telehealth, but off-label use requires documented medical rationale and informed consent
Typical Supply: 30-day trial periods common
Important Note: Same active ingredient as Wegovy; should not combine with other semaglutide products

Mounjaro/Zepbound (Tirzepatide)

Classification: Not controlled
FDA Approval: Mounjaro for Type 2 diabetes; Zepbound for obesity (approved late 2023)
Telehealth Status: Fully prescribable via telehealth
Typical Supply: 30-day titration packs
Important Note: Dual-action medication (GIP and GLP-1 agonist); requires patient training on proper injection technique

Who Qualifies for Telehealth Weight Loss Treatment?

Legitimate telehealth providers screen carefully—these are powerful medications meant for specific clinical situations, not casual cosmetic weight loss.

Standard Clinical Criteria

You typically need:

BMI ≥30 (clinical obesity), OR
BMI ≥27 with at least one weight-related comorbidity (Type 2 diabetes, hypertension, high cholesterol, sleep apnea)
Age 18 or older
Previous attempts at lifestyle modification (diet and exercise)
Commitment to ongoing monitoring and lifestyle changes

Medical History Screening

Expect comprehensive questions about:

Current medications and allergies
Personal or family history of thyroid cancer (particularly medullary thyroid carcinoma)
History of pancreatitis
Gallbladder disease
Gastrointestinal disorders
Mental health conditions (particularly eating disorders)
Pregnancy status or plans

Absolute Contraindications

You should NOT take GLP-1 medications if you have:

Personal or family history of medullary thyroid carcinoma (MTC)
Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Current pregnancy or breastfeeding
Previous severe allergic reaction to the medication
Diabetic retinopathy (relative contraindication requiring monitoring)

How the Telehealth Process Actually Works

Step 1: Initial Consultation

You’ll complete a detailed medical questionnaire covering your weight history, previous weight loss attempts, current health conditions, and medications. Most platforms require live video consultations (not just questionnaires) to establish a valid patient-provider relationship.

What to prepare:

Current height and weight (some providers may request verification photo)
List of all current medications
Recent blood pressure reading if available
Summary of weight-related health concerns

Step 2: Provider Evaluation

A licensed physician, NP, or PA reviews your information and conducts a video visit. They’ll:

Verify your eligibility based on BMI and health criteria
Discuss medication options, expected results, and realistic timelines
Review potential side effects (nausea, GI upset, injection site reactions)
Explain proper injection technique
Establish a treatment plan including lifestyle modifications

Duration: Initial consultations typically last 20-30 minutes.

Step 3: Prescription and Pharmacy

If approved, your provider sends an electronic prescription directly to your designated pharmacy. In most states, e-prescribing is mandatory for these medications.

Insurance vs. Cash Pay:

Many insurance plans now cover GLP-1s for weight loss (with prior authorization)
Cash prices vary widely: $900-$1,500/month for brand-name versions
Manufacturer savings programs may reduce costs for eligible patients

Platforms like Klarity Health provide transparent pricing upfront and accept both insurance and cash payment, ensuring you know costs before committing.

Step 4: Ongoing Monitoring

Telehealth isn’t ‘prescribe and forget.’ Legitimate providers require regular follow-ups:

First Month: Check-in at 2-4 weeks to assess tolerance, side effects, and early response
Months 2-6: Monthly or bi-monthly video visits to monitor progress, adjust dosing, and provide support
Long-term: Quarterly visits to evaluate continued need, effectiveness, and safety

Some states mandate specific follow-up schedules (Florida requires visits every 3 months; Virginia requires 30-day initial follow-up). Responsible telehealth providers exceed these minimums as standard of care.

Red Flags: How to Spot Illegitimate Telehealth Services

The popularity of GLP-1 medications has attracted bad actors. Protect yourself by avoiding services that:

🚩 Guarantee Prescriptions Without Evaluation

Legitimate providers cannot promise you’ll receive a prescription—approval depends on meeting clinical criteria. If a service guarantees medication regardless of your health status, that’s a major warning sign.

🚩 Offer Compounded or ‘Generic’ Semaglutide

After the FDA ended the shortage designation in 2024, compounded semaglutide became illegal for routine use. Some overseas sources sell supposed ‘generic’ versions—these are unregulated, potentially contaminated, and definitely illegal. Stick with FDA-approved Wegovy, Ozempic, or Zepbound from licensed U.S. pharmacies.

🚩 Skip Medical History or Provider Interaction

Real telehealth requires detailed medical intake and a live consultation with a licensed clinician. Services relying solely on automated questionnaires without provider video visits don’t meet legal standards for establishing a patient-provider relationship.

🚩 Lack Transparent Provider Credentials

You should know exactly who your provider is, their credentials (MD, DO, NP, PA), and their state license number. Services that hide provider information or use unlicensed ‘health coaches’ to prescribe are operating illegally.

🚩 Have No Follow-Up Plan

GLP-1 medications require ongoing monitoring. Services that prescribe and disappear, offering no scheduled follow-ups or safety monitoring, expose patients to serious risks (severe side effects can develop weeks into treatment).

🚩 Make Unrealistic Promises

Beware of claims like ‘Lose 50 pounds in 6 weeks!’ or ‘No diet or exercise needed!’ GLP-1s are effective but work gradually over months, and they’re most successful when combined with lifestyle changes. Overpromising results suggests the service prioritizes sales over patient safety.

The Economics: Insurance, Cash Pay, and Affordability

Insurance Coverage

Coverage for GLP-1 weight loss medications has expanded significantly:

Medicare: Currently does not cover weight loss medications (though coverage bills have been proposed)
Medicaid: Varies by state; roughly 15 states now provide some coverage
Commercial Insurance: Most major insurers cover with prior authorization, though criteria can be strict (documented BMI requirements, previous weight loss attempts, provider attestation)

Prior authorization typically requires:

BMI documentation over time
Records of previous weight loss efforts
Comorbidity documentation
Provider letter of medical necessity

Telehealth providers experienced in these medications (like Klarity Health) can help navigate the prior authorization process and provide necessary documentation.

Cash-Pay Options

For those without coverage or facing insurance barriers:

Brand-name retail: $900-$1,500/month
Manufacturer savings programs: May reduce costs to $25-$550/month for qualifying patients
Telehealth platform pricing: Some platforms negotiate better rates or offer subscription models

Klarity Health’s approach: We believe cost shouldn’t be a barrier to effective weight management. Our platform provides upfront, transparent pricing and works with both insurance and cash-pay patients. Our providers help identify the most affordable pathway for your situation—whether that’s insurance coverage, manufacturer programs, or competitive cash pricing.

State-Specific Compliance: What Your Provider Must Do

Reputable telehealth services ensure compliance with your state’s specific requirements:

Documentation Standards

All States: Comprehensive medical history, current medications, informed consent
Enhanced Documentation States (FL, NJ, VA): Detailed lifestyle counseling documentation, diet and exercise plan, risk disclosure

Follow-Up Requirements

Florida: Visit every ≤3 months during active treatment
Virginia: 30-day follow-up after initiation mandatory
Most States: Monthly monitoring during titration, then quarterly

Laboratory Monitoring

While not universally mandated, best practice includes:

Baseline: Comprehensive metabolic panel, lipid panel, A1C (if diabetic/prediabetic), thyroid function
Ongoing: Periodic metabolic panels (every 3-6 months) to monitor kidney function and electrolytes

Prescription Monitoring Programs (PMPs)

GLP-1s are not tracked in state PMPs (since they’re not controlled), but providers should still review your medication history to:

Identify potential drug interactions
Ensure you’re not taking multiple semaglutide products concurrently
Check for any controlled substances that might affect treatment decisions

Looking Ahead: The Future of Telehealth Weight Loss Treatment

Regulatory Trends

The trajectory is clear: expanded access with appropriate safeguards. Key developments to watch:

Federal Level:

The TREATS Act, reintroduced in October 2025, would permanently allow certain controlled substance prescribing via telehealth (mainly impacting addiction treatment and ADHD care, but signaling broader telehealth support)
DEA’s temporary telehealth flexibilities have been extended through December 31, 2025, with a fourth extension expected for 2026
Continued bipartisan support for telehealth expansion in Congress

State Level:

Five states considering bills in 2026 to expand NP/PA prescribing authority (including Mississippi, Pennsylvania)
Trend toward standardizing telehealth regulations across states
Growing participation in interstate licensure compacts, making multi-state practice easier for providers

Emerging Medications

The GLP-1 market continues evolving:

Oral semaglutide (Rybelsus) offers pill alternative to injections
New dual/triple agonists in clinical trials showing even greater efficacy
Biosimilar competition expected to reduce costs in coming years

Technology Integration

Expect to see:

AI-assisted monitoring: Platforms tracking patient-reported outcomes, predicting side effects, personalizing dose adjustments
Remote monitoring devices: Smart scales, continuous glucose monitors integrated with telehealth platforms
Virtual support groups: Peer communities embedded in telehealth apps
Enhanced privacy protections: Compliance with emerging state privacy laws (like Washington’s My Health My Data Act)

Why Choose a Specialized Telehealth Platform Like Klarity Health

Not all telehealth is created equal. When it comes to weight loss medications requiring long-term management, specialized platforms offer distinct advantages:

Provider Expertise

General telehealth platforms may connect you with a provider who rarely prescribes these medications. Klarity Health’s network focuses on providers with specific experience in weight management and GLP-1 therapies—they understand nuanced dosing, manage side effects effectively, and provide evidence-based lifestyle counseling.

Availability and Accessibility

Klarity prioritizes provider availability, offering flexible appointment times including evenings and weekends. We understand that weight management is a journey requiring consistent support, not just a one-time prescription.

Transparent Pricing

We believe you deserve to know costs upfront. Whether working with your insurance or paying cash, Klarity provides clear pricing before you commit. No surprise bills, hidden fees, or confusion about what you’ll pay.

Both Insurance and Cash-Pay Options

Klarity accepts insurance for patients whose plans cover weight loss treatment, while also offering competitive cash-pay rates for those without coverage. Our team helps determine the most affordable pathway for your specific situation.

Comprehensive Care Approach

Weight loss medication is most effective as part of a comprehensive plan. Klarity providers integrate:

Medication management
Behavioral counseling
Nutrition guidance
Exercise recommendations
Mental health support when needed

This holistic approach aligns with clinical guidelines and state requirements for obesity treatment.

Your Next Steps: Getting Started Safely

If you’re considering telehealth for weight loss medications:

1. Verify Your State’s Requirements

Use the state-by-state table in this guide to understand whether you’ll need an initial in-person visit or can proceed entirely via telehealth.

2. Choose a Reputable Platform

Look for services that:

Require live video consultations with licensed providers
Clearly display provider credentials
Offer ongoing monitoring and support
Provide transparent pricing
Only prescribe FDA-approved medications
Have clear privacy policies

3. Prepare for Your Consultation

Gather:

Current height and weight
List of medications and supplements
Summary of past weight loss efforts
Questions about the medications, side effects, and expectations

4. Set Realistic Expectations

Weight loss with GLP-1s is gradual (typically 1-2 pounds per week)
Results vary individually (average 15-20% total body weight loss over 12+ months)
Medication works best with lifestyle changes
Some side effects (mainly GI) are common initially
This is a long-term commitment, not a quick fix

5. Commit to the Process

Success requires:

Attending all follow-up appointments
Reporting side effects promptly
Following dosing instructions carefully
Implementing lifestyle modifications
Maintaining open communication with your provider

Conclusion: Accessible, Legal, and Effective Weight Loss Care

The answer to ‘Can you get weight loss medications online?’ is a resounding yes—but with important caveats about doing it safely, legally, and effectively.

Telehealth has democratized access to evidence-based obesity treatment, removing barriers like geographic limitations, scheduling conflicts, and stigma around in-person weight management visits. GLP-1 medications represent a genuine breakthrough, and federal law allows prescribing via telehealth in all 50 states.

However, quality matters tremendously. The right telehealth provider doesn’t just prescribe medication—they partner with you in a comprehensive weight management journey, providing expert guidance, ongoing support, and evidence-based care tailored to your individual needs and your state’s specific requirements.

Whether you’re in a state with minimal restrictions like California or Washington, or navigating more complex requirements in places like Texas or New Jersey, understanding your local regulations empowers you to make informed decisions about your care.

Ready to explore whether telehealth weight loss treatment is right for you?

Klarity Health offers accessible, affordable obesity care with experienced providers licensed in your state. We combine the convenience of telehealth with the quality of in-person care—transparent pricing, flexible scheduling, insurance or cash-pay options, and ongoing support throughout your weight loss journey.

Schedule your consultation today to discuss your weight loss goals with a licensed provider who specializes in GLP-1 medications. Because you deserve access to safe, effective, evidence-based obesity treatment—wherever you call home.

Frequently Asked Questions

Do I need an in-person visit before getting weight loss medication through telehealth?
It depends on your state. Under federal law, no in-person visit is required for GLP-1 medications like Wegovy or Ozempic. However, some states (including Arkansas, Georgia, South Carolina, Texas, and Virginia) require or strongly recommend an initial in-person examination. Check your specific state’s requirements in our comprehensive table above.

Can nurse practitioners prescribe weight loss medications via telehealth?
Yes, nurse practitioners can prescribe GLP-1 weight loss medications in all 50 states. In over 30 states, NPs have full independent prescribing authority. In other states, NPs can prescribe with physician collaboration. Klarity ensures all NP providers operate within their state’s scope of practice.

Is it legal to get compounded semaglutide online?
No. The FDA banned routine compounding of semaglutide in May 2025 after the drug shortage ended. Only FDA-approved branded versions (Wegovy, Ozempic, Zepbound) should be prescribed and dispensed. Avoid services offering ‘compounded’ or overseas generic versions—these are illegal and potentially dangerous.

Will my insurance cover weight loss medications prescribed via telehealth?
Most commercial insurance plans cover FDA-approved weight loss medications when prescribed for appropriate medical reasons, regardless of whether the prescription comes from telehealth or in-person providers. Coverage requires prior authorization demonstrating medical necessity (appropriate BMI, comorbidities, previous weight loss efforts). Klarity can help navigate the prior authorization process.

How often do I need follow-up appointments for telehealth weight loss treatment?
Frequency varies by state and clinical need. Typical schedules include: initial follow-up at 2-4 weeks, monthly visits during the first 3-6 months (dosing adjustment phase), then quarterly visits for ongoing management. Some states mandate specific intervals—Florida requires visits every 3 months, Virginia requires a 30-day initial follow-up.

What’s the difference between Wegovy and Ozempic?
Both contain semaglutide, but Wegovy is FDA-approved specifically for weight loss (at 2.4mg dose) while Ozempic is approved for Type 2 diabetes (at lower doses). Ozempic is sometimes prescribed off-label for weight loss. Wegovy is the appropriate choice for weight management in patients without diabetes.

Research Currency Statement

Verified as of: December 17, 2025

Federal Status: DEA’s COVID-era telehealth flexibilities for controlled substances remain in effect through December 31, 2025. Non-controlled medications (including GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person requirement and can be prescribed via telehealth under federal law.

States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of December 2025)

Sources newer than 2024: 15 of 18 sources used

Note for 2026: Federal telehealth rules for controlled substances are temporary and set to expire December 31, 2025. An additional extension or new permanent rule is expected. State laws continue evolving; monitor for changes in NP practice authority and telehealth requirements.

References

DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration official announcement, November 15, 2024. www.dea.gov
COVID-era Telehealth Prescribing Extended – Axios Healthcare, November 18, 2024. Coverage of DEA’s third extension of pandemic-era telehealth flexibilities for controlled substances. www.axios.com
DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025 – McDermott Will & Emery Legal Insights, November 18, 2024. Comprehensive analysis of federal telemedicine regulations and DEA policy. www.mwe.com
Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs – Goodwin Procter Healthcare Alert, March 27, 2024. Detailed analysis of state-specific requirements for weight loss medication prescribing in Florida, New Jersey, and Virginia. www.goodwinlaw.com
Know Your State’s Laws Around Semaglutide – Nextech Healthcare Industry Blog, April 11, 2025. State-by-state compilation of prescribing requirements and in-person examination rules. www.nextech.com

Source:

Looking for support with Weight loss? Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.

Phone:

(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Fax:

(855) 975-3008

Email:

patientsupport@helloklarity.com

Mailing Address:

1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.